Gillian M Howell相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Selective Inhibition of Histone Deacetylases 1/2/6 in Combination with Gemcitabine: A Promising Combination for Pancreatic Cancer Therapy

选择性抑制组蛋白去乙酰化酶 1/2/6 与吉西他滨联合治疗：一种有前景的胰腺癌治疗组合

doi:10.3390/cancers11091327

Richard S Laschanzky, Lisa E Humphrey, Jihyun Ma, Lynette M Smith, Thomas J Enke, Surendra K Shukla, Aneesha Dasgupta, Pankaj K Singh, Gillian M Howell, Michael G Brattain, Quan P Ly, Adrian R Black, Jennifer D Black

发表日期：2019

文献求助收藏

Histone deacetylase inhibitor belinostat represses survivin expression through reactivation of transforming growth factor beta (TGFbeta) receptor II leading to cancer cell death

组蛋白去乙酰化酶抑制剂 belinostat 通过重新激活转化生长因子 β (TGFbeta) 受体 II 来抑制 survivin 表达，从而导致癌细胞死亡

期刊:Journal of Biological Chemistry

doi:10.1074/jbc.M110.212035

Sanjib Chowdhury, Gillian M Howell, Carol A Teggart, Aparajita Chowdhury, Jonathan J Person, Dawn M Bowers, Michael G Brattain

细胞生物学

发表日期：2011

文献求助收藏

Identification of a novel TGFβ/PKA signaling transduceome in mediating control of cell survival and metastasis in colon cancer

鉴定一种新型 TGFβ/PKA 信号传导组，介导控制结肠癌细胞存活和转移

期刊:PLoS One

影响因子:2.9

doi:10.1371/journal.pone.0019335

Sanjib Chowdhury, Gillian M Howell, Ashwani Rajput, Carol A Teggart, Lisa E Brattain, Hannah R Weber, Aparajita Chowdhury, Michael G Brattain

发表日期：2011

文献求助收藏